Back to News
Market Impact: 0.15
InnovAge Prices Secondary Offering Of 10 Mln Shares At $9.25/Shr; Stock Down
Source: Nasdaq
Healthcare & Biotech
InnovAge Holding announced the pricing of a secondary common-stock offering by existing selling stockholders. The article provides no offering size or price; because the shares are being sold by stockholders, the transaction does not indicate direct primary capital proceeds for InnovAge.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.05
More News
- Street Calls of The Week
- argenx reports positive phase 3 data for autoimmune myositis drug
- Why the prognosis for healthcare stocks is uncertain ahead of Congress’ new makeup
- AtriCure: A New Quality Metric Could Put A Clip In Nearly Every Sternotomy
- J&J presents patient data on nipocalimab for Sjögren’s disease
- Rent-a-grandchild: Businesses offering companions to elderly grow in India